Barbican Dental Care has been acquired by Bupa Dental Services
The shareholders of Barbican Dental Care have sold the company to Bupa Dental Services (Bupa), the UK-based international healthcare group. Financial terms of this transaction have not been disclosed.
Barbican Dental Care is a specialist corporate dental business, offering affordable private dental care and corporate dental plans to companies based in the City, West End and Canary Wharf. The 24 surgeries operate from nine sites providing general, specialist and cosmetic dentistry.
Bupa provides international healthcare support and advisory services. This transaction meets Bupa’s strategy to acquire high quality private practices based in locations that are convenient for corporate and business centers.
Neil Sikka, who founded Barbican Dental Care in 1992, said: “I am very excited about the opportunity to grow the business within Bupa Dental Services and look forward to working with Bupa on the initial integration and subsequent expansion of their dental services.”
Oaklins Cavendish, based in the UK, advised the shareholders of Barbican Dental Care in this transaction. The team's specialist commented: “Barbican Dental Care’s unique business-to-business service proposition and high quality, well run private surgeries generated significant interest. Neil has successfully developed the business through his constant focus on the provision of high quality private dental services in state-of-the-art facilities.”


Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more